Blog

Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study

FDA Launches Digital Health Center of Excellence

Successful project delivery through laboratory and clinical integration

RACE Act: A Promising Catalyst for Improved Pediatric Cancer Treatments

Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)

PPD Heroes: Advocating for the patient’s voice during COVID-19

How an FSP model can ensure business continuity during COVID-19

Mitigating impacts of a global pandemic in the clinical development space

Regulatory Insights: Adaptive Clinical Trial Design – Overview and Critical Success Factors